Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1679628 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $0.10Day −9.75%Mkt cap $4M1Y −93.0%Off 52W high −94.6%Vol (1Y) 114.0%
Daily closing price, split-adjusted to the current basis; 1.6y shown of 406 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.7% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)+2.88% |
| Top-10 13F concentration100.0% |
| Next report (est.)2026-08-13 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$21,796 |
| Earnings (TTM)-$9.2M |
| Net margin−39662.8% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD−90.3% |
| 1Y−93.0% |
| Since incept. (ann.)−91.2% |
Total return through 2026-07-29 · series begins 2024-12-03. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)114.0% |
| Ann. volatility (3Y)148.1% |
| Sharpe (1Y)−1.89 |
| Sharpe (3Y)−0.89 |
| Max drawdown (1Y)−94.5% |
| Max drawdown (3Y)−99.4% |
| Beta (3Y vs SPY)2.23 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| VESTOR CAPITAL, LLC | 970,985 | $365,000 | 2.68% | +144607.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 359,911 | $135,327 | 0.99% | new |
| GEODE CAPITAL MANAGEMENT, LLC | 211,696 | $79,639 | 0.58% | +59.6% |
| Yorkville Advisors Global, LP | 129,000 | $48,530 | 0.36% | −2.2% |
| CITADEL ADVISORS LLC | 101,661 | $38,245 | 0.28% | new |
| VANGUARD FIDUCIARY TRUST CO | 87,789 | $33,009 | 0.24% | new |
| NORTHERN TRUST CORP | 25,346 | $9,535 | 0.07% | +0.0% |
| Virtu Financial LLC | 13,575 | $5,000 | 0.04% | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | −$0.06 | — | $18,652 | — |
| 2025-09-30 | 2025-11-14 | −$0.07 | — | — | — |
| 2025-06-30 | 2025-08-19 | −$0.07 | −800.0% | — | — |
| 2025-03-31 | 2025-05-15 | −$0.05 | — | $0 | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-13 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
